分子細胞遺伝市場規模、シェア、動向分析レポート：用途別、技術別、製品別、最終用途別、地域別、セグメント予測、2023年～2030年

分子細胞遺伝市場の成長と動向：

Grand View Research社の最新レポートによると、世界の分子細胞遺伝市場規模は2030年までに44億6,000万米ドルに達すると予測されています。

同市場は2023年から2030年にかけてCAGR 10.6％で拡大すると予測されています。臨床病理検査における分子細胞遺伝学の浸透の高まり、標的がん治療への傾斜の高まり、個別化医療への注目の高まりが成長を促進する主な要因です。また、遺伝性疾患の罹患率の増加、分子細胞遺伝分野の技術進歩、研究開発活動の活発化が、予測期間中の市場拡大を促進すると予想されます。

さらに、ハイスループットシーケンサーの統合によって実施される細胞遺伝学的解析も、今後数年間の成長を大幅に押し上げると予想される要因の1つです。多くの科学者や研究者がNGSと細胞遺伝学研究所を統合しており、これらは互いに準拠しています。このように、シーケンス価格の大幅な下落により、市場はかなりのペースで成長すると推定されます。

COVID-19の流行は分子細胞遺伝市場にプラスの影響を与えています。検査の優先順位が変化したため、分子細胞遺伝学研究所はCOVID-19診断検査の実施に方向転換されました。さらに、公衆衛生ゲノミクスへの注目の高まりは、集団ベースのゲノムサーベイランスと疾病伝播の追跡における分子細胞遺伝学の価値を浮き彫りにし、効果的な公衆衛生戦略の開発に貢献しています。このように、パンデミック時の診断検査の高い発生率が、分子細胞遺伝市場の成長に拍車をかけています。

ダウン症候群、サラセミア、嚢胞性線維症などの遺伝性疾患の発生率の増加は、予測される期間中にセグメントの成長を促進すると予想されます。例えば、WHOの推計によると、1000人中約10人が遺伝性疾患に罹患しており、これは全世界で約7000万人から8,000万人に相当します。さらに、細胞遺伝学的ツールの技術的進歩に対する事業者による戦略的イニシアチブの高まりが、分子細胞遺伝市場を促進すると予測されています。例えば、2022年10月、Genoox社はThermo Fisher Scientific社と提携し、CytoScan Automated Interpretation and Reporting（AIR）ソリューションを発表しました。このツールは細胞遺伝学的研究データ解析を容易にすると期待されています。

分子細胞遺伝市場レポートハイライト

• 用途別では、がん分野が2022年に39.70%のシェアで市場を独占しました。これは、CGH技術ががん病因の詳細な研究を可能にするためです。
• 製品別では、遺伝子疾患と個別化医療に関する知識と意識の高まりにより、消耗品が2022年に39.51%のシェアを占めました。
• 技術別では、より良い染色体分析のための技術進歩の高まりにより、比較ゲノムハイブリダイゼーション分野が2022年の分子細胞遺伝市場を独占しました。
• 最終用途別では、臨床＆研究ラボ部門が2022年の収益シェアの大半を占めました。一方、製薬＆バイオ企業セグメントは、予測期間中に最も速いCAGRを示すと予測されています。
• 2022年、北米は、技術の進歩、ヘルスケアインフラの改善、大手企業の存在、同地域における医薬品臨床試験とその承認件数の増加により、業界を支配しました。

目次

第1章 分子細胞遺伝市場：調査手法と範囲

第2章 分子細胞遺伝市場：エグゼクティブサマリー

• 市場の見通し
• アプリケーションとテクノロジーのスナップショット
• 製品と最終用途のスナップショット
• 競合情勢のスナップショット

第3章 分子細胞遺伝市場：市場変数、動向および範囲

• 市場系統の見通し
• 市場力学
• 業界分析ツール

第4章 分子細胞遺伝市場：用途のビジネス分析

• 分子細胞遺伝市場：用途の変動分析
• 遺伝性疾患
• オンコロジー
• 個別化医療
• その他の用途

第5章 分子細胞遺伝市場：技術のビジネス分析

• 分子細胞遺伝市場：技術の変動分析
• 比較ゲノムハイブリダイゼーション
• FISH
• 免疫組織化学
• 核型分析
• その他

第6章 分子細胞遺伝市場：製品のビジネス分析

• 分子細胞遺伝市場：製品の変動分析
• 機器
• 消耗品
• ソフトウェアとサービス

第7章 分子細胞遺伝市場：最終用途のビジネス分析

• 分子細胞遺伝市場：最終用途の変動分析
• 臨床および研究機関
• 病院とパスラボ
• 学術調査機関
• 製薬会社およびバイオテクノロジー企業
• その他

第8章 分子細胞遺伝市場：地域のビジネス分析

• 地域市場のスナップショット
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第9章 分子細胞遺伝市場：競合情勢

• 企業の分類
• 戦略マッピング
• 企業の市場シェア分析、2022年
• 企業プロファイル

第10章 KOLの推奨事項/アナリストの視点

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviation
• Table 3. North America molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
• Table 4. North America molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 5. North America molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 6. North America molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 7. North America molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 8. U.S. molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 9. U.S. molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 10. U.S. molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 11. U.S. molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 12. Canada molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 13. Canada molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 14. Canada molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 15. Canada molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 16. Europe molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
• Table 17. Europe molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 18. Europe molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 19. Europe molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 20. Europe molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 21. UK molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 22. UK molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 23. UK molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 24. UK molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 25. Germany molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 26. Germany molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 27. Germany molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 28. Germany molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 29. France molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 30. France molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 31. France molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 32. France molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 33. Italy molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 34. Italy molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 35. Italy molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 36. Italy molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 37. Spain molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 38. Spain molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 39. Spain molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 40. Spain molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 41. Denmark molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 42. Denmark molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 43. Denmark molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 44. Denmark molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 45. Sweden molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 46. Sweden molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 47. Sweden molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 48. Sweden molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 49. Norway molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 50. Norway molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 51. Norway molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 52. Norway molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 53. Asia Pacific molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
• Table 54. Asia Pacific molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 55. Asia Pacific molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 56. Asia Pacific molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 57. Asia Pacific molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 58. China molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 59. China molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 60. China molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 61. China molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 62. Japan molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 63. Japan molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 64. Japan molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 65. Japan molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 66. South Korea molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 67. South Korea molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 68. South Korea molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 69. South Korea molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 70. Australia molecular cytogenetics market, by application 2018 - 2030 (USD Million)
• Table 71. Australia molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 72. Australia molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 73. Australia molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 74. Thailand molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 75. Thailand molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 76. Thailand molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 77. Thailand molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 78. India molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 79. India molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 80 India molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 81. India molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 82. Latin America molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
• Table 83. Latin America molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 84. Latin America molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 85. Latin America molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 86. Latin America molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 87. Brazil molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 88. Brazil molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 89. Brazil molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 90. Brazil molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 91. Mexico molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 92. Mexico molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 93. Mexico molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 94. Mexico molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 95. Argentina molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 96. Argentina molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 97. Argentina molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 98. Argentina molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 99. Middle East & Africa molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
• Table 100. Middle East & Africa molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 101. Middle East & Africa molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 102. Middle East & Africa molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 103. Middle East & Africa molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 104. South Africa molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 105. South Africa molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 106. South Africa molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 107. South Africa molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 108. Saudi Arabia molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 109. Saudi Arabia molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 110. Saudi Arabia molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 111. Saudi Arabia molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 112. UAE molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 113. UAE molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 114. UAE molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 115. UAE molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
• Table 116. Kuwait molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
• Table 117. Kuwait molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
• Table 118. Kuwait molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
• Table 119. Kuwait molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Molecular cytogenetics market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Segment snapshot
• Fig. 12 Competitive landscape
• Fig. 13 Molecular Cytogenetics Market Value, 2022 (USD Billion)
• Fig. 14 Molecular Cytogenetics - Industry value chain analysis
• Fig. 15 Molecular cytogenetics market dynamics
• Fig. 16 Molecular cytogenetics market: PORTER's Five Forces analysis
• Fig. 17 Molecular cytogenetics market: PESTEL analysis
• Fig. 20 Molecular cytogenetics market: By application: Key takeaways
• Fig. 21 Molecular cytogenetics market, by application: Market share, 2022 & 2030
• Fig. 22 Genetic disorders market, 2018 - 2030 (USD Million)
• Fig. 23 Oncology market, 2018 - 2030 (USD Million)
• Fig. 24 Personalized medicine market, 2018 - 2030 (USD Million)
• Fig. 25 Other application market, 2018 - 2030 (USD Million)
• Fig. 26 Molecular cytogenetics market: By technology: Key takeaways
• Fig. 27 Molecular cytogenetics market, by technology: Market share, 2022 & 2030
• Fig. 28 Comparative genomic hybridization market, 2018 - 2030 (USD Million)
• Fig. 29 aCGH market, 2018 - 2030 (USD Million)
• Fig. 30 sCGH market, 2018 - 2030 (USD Million)
• Fig. 31 FISH market, 2018 - 2030 (USD Million)
• Fig. 32 Immunohistochemistry market, 2018 - 2030 (USD Million)
• Fig. 33 Karyotyping market, 2018 - 2030 (USD Million)
• Fig. 34 Spectral market, 2018 - 2030 (USD Million)
• Fig. 35 Virtual market, 2018 - 2030 (USD Million)
• Fig. 36 Others market, 2018 - 2030 (USD Million)
• Fig. 37 Molecular cytogenetics market: By product: Key takeaways
• Fig. 38 Molecular cytogenetics market, by product: Market share, 2022 & 2030
• Fig. 39 Instruments market, 2018 - 2030 (USD Million)
• Fig. 40 Consumables market, 2018 - 2030 (USD Million)
• Fig. 41 Software & services market, 2018 - 2030 (USD Million)
• Fig. 42 Molecular cytogenetics market: By end use: Key takeaways
• Fig. 43 Molecular cytogenetics market, by end use: Market share, 2022 & 2030
• Fig. 44 Clinical & research laboratories market, 2018 - 2030 (USD Million)
• Fig. 45 Hospitals & path labs market, 2018 - 2030 (USD Million)
• Fig. 46 Academic research institutes market, 2018 - 2030 (USD Million)
• Fig. 47 Pharmaceutical & biotech companies market, 2018 - 2030 (USD Million)
• Fig. 48 Others market, 2018 - 2030 (USD Million)
• Fig. 49 Molecular cytogenetics market revenue share, by region, 2022 & 2030 (USD Million)
• Fig. 50 Regional marketplace: Key takeaways
• Fig. 51 Regional marketplace: Key takeaways
• Fig. 52 North America: SWOT analysis
• Fig. 53 North America molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 Reimbursement procurement process
• Fig. 56 U.S. molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 Canada molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Europe: SWOT analysis
• Fig. 60 Europe molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 Germany molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 UK molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 France molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 Italy molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 Spain molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Denmark molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 Sweden molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 Norway molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Asia Pacific: SWOT analysis
• Fig. 78 Asia Pacific molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Key country dynamics
• Fig. 80 Reimbursement procurement process
• Fig. 81 Japan molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 China molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 India molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Key country dynamics
• Fig. 87 Australia molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 South Korea molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 Thailand molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Latin America: SWOT analysis
• Fig. 93 Latin America molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Key country dynamics
• Fig. 95 Brazil molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Key country dynamics
• Fig. 97 Mexico molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98 Key country dynamics
• Fig. 99 Argentina molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 100 MEA: SWOT analysis
• Fig. 101 Middle East & Africa molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 102 Key country dynamics
• Fig. 103 South Africa molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 104 Key country dynamics
• Fig. 105 Saudi Arabia molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 106 Key country dynamics
• Fig. 107 UAE molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 108 Key country dynamics
• Fig. 109 Kuwait molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 110 Key company categorization
• Fig. 111 Company market position analysis
• Fig. 112 Strategic framework

Molecular Cytogenetics Market Growth & Trends:

The global molecular cytogenetics market size is anticipated to reach USD 4.46 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 10.6% from 2023 to 2030. Rising penetration of molecular cytogenetics in clinical pathological testing, growing inclination towards targeted cancer treatment, and increasing focus on personalized medicine are the key factors driving growth. In addition, the increasing incidence of genetic disorders, technological advancements in the field of molecular cytogenetics, and rising R&D activities are anticipated to drive market expansion over the forecast period.

Furthermore, the cytogenetic analysis carried out through the integration of high throughput sequencers is another factor that is expected to significantly boost growth in the coming years. A number of scientists and researchers integrate NGS with cytogenetics laboratories as they are compliant with one another. Thus, with a significant drop in sequencing prices, the market is estimated to grow at a substantial pace.

The COVID-19 pandemic has positively impacted the market for molecular cytogenetics. Due to the shift in testing priorities, molecular cytogenetics laboratories were being redirected to conduct COVID-19 diagnostic testing. Furthermore, the increased focus on public health genomics has highlighted the value of molecular cytogenetics in population-based genomic surveillance and tracking disease spread, contributing to the development of effective public health strategies. Thus, the high incidence of diagnostic testing during the pandemic has fueled the growth of the market for molecular cytogenetics.

Increasing incidences of genetic disorders such as Down syndrome, Thalassemia, and Cystic Fibrosis are anticipated to fuel segment growth during the projected timeframe. For instance, according to WHO estimates, about 10 out of every 1000 people are affected with genetic disorders, which is approximately 70-80 million people globally. Moreover, rising strategic initiatives by operating players for technological advancements in cytogenetic tools are projected to propel the market for molecular cytogenetics. For instance, in October 2022, Genoox partnered with Thermo Fisher Scientific to introduce the CytoScan Automated Interpretation and Reporting (AIR) solution. This tool is expected to ease cytogenetic research data analysis.

Molecular Cytogenetics Market Report Highlights:

• Based on application, the oncology segment dominated the market with a share of 39.70% in 2022, due to the capability of the CGH technology to avail detailed studies for cancer etiology
• Based on product, consumables dominated the segment with a share of 39.51% in 2022, owing to the increasing knowledge and awareness regarding genetic diseases and personalized medicines
• Based on technology, the comparative genomic hybridization segment dominated the market for molecular cytogenetics in 2022 due to the rising technological advancements for better chromosomal analysis
• Based on end-use, the clinical & research laboratories segment held a majority of the revenue share in 2022. On the other hand, the pharmaceutical & biotech companies segment is anticipated to witness the fastest CAGR over the forecast period
• In 2022, North America dominated the industry owing to the rising technological advancements, improving healthcare infrastructure, the presence of major players, and the increasing number of drug trials and their approvals in the region

Table of Contents

Chapter 1 Molecular Cytogenetics Market: Research Methodology And Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment Definitions
    • 1.1.1.1 Application Segment
    • 1.1.1.2 Technology Segment
    • 1.1.1.3 Product Segment
    • 1.1.1.4 End Use Segment
• 1.2 Regional Scope
• 1.3 Estimates and Forecast Timeline
• 1.4 Objectives
  • 1.4.1 Objective - 1
  • 1.4.2 Objective - 2
  • 1.4.3 Objective - 3
• 1.5 Research Methodology
• 1.6 Information Procurement
  • 1.6.1 Purchased Database
  • 1.6.2 Gvr's Internal Database
  • 1.6.3 Secondary Sources
  • 1.6.4 Primary Research
• 1.7 Information or Data Analysis
  • 1.7.1 Data Analysis Models
• 1.8 Market Formulation & Validation
• 1.9 Model Details
  • 1.9.1 Commodity Flow Analysis
• 1.10 List Of Secondary Sources
• 1.11 List Of Abbreviations

Chapter 2 Molecular Cytogenetics Market: Executive Summary

• 2.1 Market Outlook
• 2.2 Application And Technology Snapshot
• 2.3 Product And End Use Snapshot
• 2.4 Competitive Landscape Snapshot

Chapter 3 Molecular Cytogenetics Market: Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Related/Ancillary Market Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Drivers Analysis
    • 3.2.1.1 Rapid technological advancements
    • 3.2.1.2 Increasing prevalence of genetic disorders
    • 3.2.1.3 Growing application in oncology
    • 3.2.1.4 Increasing demand for personalized medicine
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 High Costs Of Testing
    • 3.2.2.2 Lack Of Reimbursement Policies
• 3.3 Industry Analysis Tools
  • 3.3.1 Porter's Five Forces Analysis
  • 3.3.2 Pestel Analysis

Chapter 4 Molecular Cytogenetics Market: Application Business Analysis

• 4.1 Molecular Cytogenetics Market: Application Movement Analysis
• 4.2 Genetic Disorders
  • 4.2.1 Genetic Disorders Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.3 Oncology
  • 4.3.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.4 Personalized Medicine
  • 4.4.1 Personalized Medicine Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.5 Other Application
  • 4.5.1 Other Application Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Molecular Cytogenetics Market: Technology Business Analysis

• 5.1 Molecular Cytogenetics Market: Technology Movement Analysis
• 5.2 Comparative Genomic Hybridisation
  • 5.2.1 Comparative Genomic Hybridisation Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.2.2 ACGH
    • 5.2.2.1 ACGH Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.2.3 SCGH
    • 5.2.3.1 SCGH Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.3 Fish
  • 5.3.1 Fish Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.4 Immunohistochemistry
  • 5.4.1 Immunohistochemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.5 Karyotyping
  • 5.5.1 Karyotyping Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5.2 Spectral
    • 5.5.2.1 Spectral Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5.3 Virtual
    • 5.5.3.1 Virtual Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.6 Others
  • 5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Molecular Cytogenetics Market: Product Business Analysis

• 6.1 Molecular Cytogenetics Market: Product Movement Analysis
• 6.2 Instruments
  • 6.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.3 Consumables
  • 6.3.1 Consumables Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.4 Software & Services
  • 6.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Molecular Cytogenetics Market: End Use Business Analysis

• 7.1 Molecular Cytogenetics Market: End Use Movement Analysis
• 7.2 Clinical & Research Laboratories
  • 7.2.1 Clinical & Research Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.3 Hospitals & Path Labs
  • 7.3.1 Hospitals & Path Labs Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.4 Academic Research Institutes
  • 7.4.1 Academic Research Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.5 Pharmaceutical & Biotech Companies
  • 7.5.1 Pharmaceutical & Biotech Companies Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.6 Others
  • 7.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Molecular Cytogenetics Market: Regional Business Analysis

• 8.1 Regional Market Snapshot
• 8.2 North America
  • 8.2.1 North America Molecular Cytogenetics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.2.2 U.S.
    • 8.2.2.1 U.S. Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.2.2.2 Key Country Dynamics
    • 8.2.2.3 Regulatory Framework
    • 8.2.2.4 Reimbursement Scenario
  • 8.2.3 Canada
    • 8.2.3.1 Canada Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.2.3.2 Key Country Dynamics
    • 8.2.3.3 Regulatory Framework
    • 8.2.3.4 Reimbursement Scenario
• 8.3 Europe
  • 8.3.1 Europe Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
  • 8.3.2 UK
    • 8.3.2.1 UK Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.3.2.2 Key Country Dynamics
    • 8.3.2.3 Regulatory Framework
    • 8.3.2.4 Reimbursement Scenario
  • 8.3.3 Germany
    • 8.3.3.1 Germany Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.3.3.2 Key Country Dynamics
    • 8.3.3.3 Regulatory Framework
    • 8.3.3.4 Reimbursement Scenario
  • 8.3.4 Spain
    • 8.3.4.1 Spain Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.3.4.2 Key Country Dynamics
    • 8.3.4.3 Regulatory Framework
    • 8.3.4.4 Reimbursement Scenario
  • 8.3.5 France
    • 8.3.5.1 France Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.3.5.2 Key Country Dynamics
    • 8.3.5.3 Regulatory Framework
    • 8.3.5.4 Reimbursement Scenario
  • 8.3.6 Italy
    • 8.3.6.1 Italy Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.3.6.2 Key Country Dynamics
    • 8.3.6.3 Regulatory Framework
    • 8.3.6.4 Reimbursement Scenario
  • 8.3.7 Denmark
    • 8.3.7.1 Denmark Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.3.7.2 Key Country Dynamics
    • 8.3.7.3 Regulatory Framework
    • 8.3.7.4 Reimbursement Scenario
  • 8.3.8 Sweden
    • 8.3.8.1 Sweden Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.3.8.2 Key Country Dynamics
    • 8.3.8.3 Regulatory Framework
    • 8.3.8.4 Reimbursement Scenario
  • 8.3.9 Norway
    • 8.3.9.1 Norway Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.3.9.2 Key Country Dynamics
    • 8.3.9.3 Regulatory Framework
    • 8.3.9.4 Reimbursement Scenario
• 8.4 Asia Pacific
  • 8.4.1 Asia-Pacific Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
  • 8.4.2 Japan
    • 8.4.2.1 Japan Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.4.2.2 Key Country Dynamics
    • 8.4.2.3 Regulatory Framework
    • 8.4.2.4 Reimbursement Scenario
  • 8.4.3 China
    • 8.4.3.1 China Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.4.3.2 Key Country Dynamics
    • 8.4.3.3 Regulatory Framework
    • 8.4.3.4 Reimbursement Scenario
  • 8.4.4 India
    • 8.4.4.1 India Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.4.4.2 Key Country Dynamics
    • 8.4.4.3 Regulatory Framework
    • 8.4.4.4 Reimbursement Scenario
  • 8.4.5 South Korea
    • 8.4.5.1 South Korea Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.4.5.2 Key Country Dynamics
    • 8.4.5.3 Regulatory Framework
    • 8.4.5.4 Reimbursement Scenario
  • 8.4.6 Thailand
    • 8.4.6.1 Thailand Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.4.6.2 Key Country Dynamics
    • 8.4.6.3 Regulatory Framework
    • 8.4.6.4 Reimbursement Scenario
  • 8.4.7 Australia
    • 8.4.7.1 Australia Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.4.7.2 Key Country Dynamics
    • 8.4.7.3 Regulatory Framework
    • 8.4.7.4 Reimbursement Scenario
• 8.5 Latin America
  • 8.5.1 Latin America Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
  • 8.5.2 Brazil
    • 8.5.2.1 Brazil Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.5.2.2 Key Country Dynamics
    • 8.5.2.3 Regulatory Framework
    • 8.5.2.4 Reimbursement Scenario
  • 8.5.3 Mexico
    • 8.5.3.1 Mexico Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.5.3.2 Key Country Dynamics
    • 8.5.3.3 Regulatory Framework
    • 8.5.2.4 Reimbursement Scenario
  • 8.5.4 Argentina
    • 8.5.4.1 Argentina Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.5.4.2 Key Country Dynamics
    • 8.5.4.3 Regulatory Framework
    • 8.5.4.4 Reimbursement Scenario
• 8.6 MEA
  • 8.6.1 MEA Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
  • 8.6.2 South Africa
    • 8.6.2.1 South Africa Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.6.2.2 Key Country Dynamics
    • 8.6.2.3 Regulatory Framework
    • 8.6.2.4 Reimbursement Scenario
  • 8.6.3 Saudi Arabia
    • 8.6.3.1 Saudi Arabia Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.6.3.2 Key Country Dynamics
    • 8.6.3.3 Regulatory Framework
    • 8.6.3.4 Reimbursement Scenario
  • 8.6.4 UAE
    • 8.6.4.1 UAE Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.6.4.2 Key Country Dynamics
    • 8.6.4.3 Regulatory Framework
    • 8.6.2.4 Reimbursement Scenario
  • 8.6.5 Kuwait
    • 8.6.5.1 Kuwait Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.6.5.2 Key Country Dynamics
    • 8.6.5.3 Regulatory Framework
    • 8.6.5.4 Reimbursement Scenario

Chapter 9 Molecular Cytogenetics Market: Competitive Landscape

• 9.1 Company Categorization
• 9.2 Strategy Mapping
  • 9.2.1 New product launch
  • 9.2.2 Partnerships
  • 9.2.3 Acquisition
  • 9.2.4 Collaboration
  • 9.2.5 Funding
• 9.3 Company Market Share Analysis, 2022
• 9.4 Company Profiles
  • 9.4.1 BIOVIEW
    • 9.4.1.1 Company overview
    • 9.4.1.2 Financial performance
    • 9.4.1.3 Product benchmarking
    • 9.4.1.4 Strategic initiatives
  • 9.4.2 DANAHER
    • 9.4.2.1 Company overview
    • 9.4.2.1.1 Leica Biosystems Nussloch GmbH
    • 9.4.2.2 Financial performance
    • 9.4.2.3 Product benchmarking
    • 9.4.2.4 Strategic initiatives
  • 9.4.3 METASYSTEMS
    • 9.4.3.1 Company overview
    • 9.4.3.2 Financial performance
    • 9.4.3.3 Product benchmarking
    • 9.4.3.4 Strategic initiatives
  • 9.4.4 AGILENT TECHNOLOGIES, INC.
    • 9.4.4.1 Company overview
    • 9.4.4.2 Financial performance
    • 9.4.4.3 Product benchmarking
    • 9.4.4.4 Strategic initiatives
  • 9.4.5 ABBOTT
    • 9.4.5.1 Company overview
    • 9.4.5.2 Financial performance
    • 9.4.5.3 Product benchmarking
    • 9.4.5.4 Strategic initiatives
  • 9.4.6 BIO-RAD LABORATORIES, INC.
    • 9.4.6.1 Company overview
    • 9.4.6.2 Financial performance
    • 9.4.6.3 Product benchmarking
    • 9.4.6.4 Strategic initiatives
  • 9.4.7 ILLUMINA, INC.
    • 9.4.7.1 Company overview
    • 9.4.7.2 Financial performance
    • 9.4.7.3 Product benchmarking
    • 9.4.7.4 Strategic initiatives
  • 9.4.8 OXFORD GENE TECHNOLOGY
    • 9.4.8.1 Company overview
    • 9.4.8.2 Financial performance
    • 9.4.8.3 Product benchmarking
    • 9.4.8.4 Strategic initiatives
  • 9.4.9 F. HOFFMANN-LA ROCHE LTD
    • 9.4.9.1 Company overview
    • 9.4.9.1.1 Genentech, Inc.
    • 9.4.9.2 Financial performance
    • 9.4.9.4 Product benchmarking
    • 9.4.9.5 Strategic initiatives
  • 9.4.10 PERKINELMER INC.
    • 9.4.10.1 Company overview
    • 9.4.10.2 Financial performance
    • 9.4.10.3 Product benchmarking
    • 9.4.10.4 Strategic initiatives
  • 9.4.11 QUEST DIAGNOSTICS INCORPORATED
    • 9.4.11.1 Company overview
    • 9.4.11.1.1 Sonora Quest Laboratories
    • 9.4.11.2 Financial performance
    • 9.4.11.3 Product benchmarking
    • 9.4.11.4 Product benchmarking
    • 9.4.11.5 Strategic initiatives
  • 9.4.12 APPLIED SPECTRAL IMAGING
    • 9.4.12.1 Company overview
    • 9.4.12.2 Financial performance
    • 9.4.12.3 Product benchmarking
    • 9.4.12.4 Strategic initiatives
  • 9.4.13 BIOLOGICAL INDUSTRIES USA, INC.
    • 9.4.13.1 Company overview
    • 9.4.13.2 Financial performance
    • 9.4.13.3 Product benchmarking
    • 9.4.13.4 Strategic initiatives
  • 9.4.14 CYTOTEST
    • 9.4.14.1 Company overview
    • 9.4.14.2 Financial performance
    • 9.4.14.3 Product benchmarking
    • 9.4.14.4 Strategic initiatives
  • 9.4.15 CYTOGNOMIX
    • 9.4.15.1 Company overview
    • 9.4.15.2 Financial performance
    • 9.4.15.3 Product benchmarking
  • 9.4.16 GENIAL GENETICS
    • 9.4.16.1 Company overview
    • 9.4.16.2 Financial performance
    • 9.4.16.3 Product benchmarking
    • 9.4.16.4 Strategic initiatives
  • 9.4.17 DIAGNOSTIC CYTOGENETICS, INC. (DCI)
    • 8.4.17.1 Company overview
    • 8.4.17.2 Financial performance
    • 8.4.17.3 Product benchmarking

Chapter 10 KOL Recommendations/Analyst Perspective